19 Patent Results (17 families)
Make Note

Uses And Compositions For Treatment Of Psoriasis

  • Published: Nov 27, 2013
  • Filed: Apr 10, 2007
  • Earliest Priority: Apr 10 2006
  • Family: 8
  • Cited Works: 132
  • Cited by: 1
  • Cites: 53
  • Sequences: 37
  • Additional Info: Cited Works Published Sequence
  • Applicant: Abbott Biotech Ltd
Patent Application
EP 2666478 A2
069-129-375-615-783

Pharmaceutical Composition Comprising A Glp-1 Agonist And Methionine

  • Published: Jul 18, 2017
  • Filed: Nov 11, 2010
  • Earliest Priority: Nov 13 2009
  • Family: 55
  • Cited Works: 849
  • Cited by: 1
  • Cites: 529
  • Additional Info: Cited Works Full text Published
  • Owner: Sanofi-aventis Deutschland Gmbh
  • Applicant: Brunner-schwarz Anette, Mueller Werner, Siefke-henzler Verena, Sanofi Aventis Deutschland
Granted Patent
US 9707176 B2
002-447-756-954-909

Pharmaceutical Composition Comprising A Glp-1-agonist And Methionine

  • Published: Jul 24, 2018
  • Filed: May 15, 2017
  • Earliest Priority: Nov 13 2009
  • Family: 55
  • Cited Works: 971
  • Cited by: 0
  • Cites: 520
  • Sequences: 4
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Sanofi-aventis Deutschland Gmbh
  • Applicant: Sanofi Aventis Deutschland
Granted Patent
US 10028910 B2
099-183-108-461-543

Tranexamic Acid Formulations

  • Published: Sep 20, 2011
  • Filed: Apr 30, 2009
  • Earliest Priority: Mar 04 2004
  • Family: 2
  • Cited Works: 102
  • Cited by: 8
  • Cites: 81
  • Additional Info: Cited Works Full text Published
  • Owner: Ferring B.v, Mikart Inc, Xanodyne Pharmaceuticals Inc, Xanodyne Pharmaceuticals
  • Applicant: Ferring Bv
Granted Patent
US 8022106 B2
138-143-510-322-775

Tranexamic Acid Formulations With Reduced Adverse Effects

  • Published: Mar 3, 2015
  • Filed: Feb 3, 2006
  • Earliest Priority: Jul 31 2003
  • Family: 8
  • Cited Works: 105
  • Cited by: 0
  • Cites: 102
  • Additional Info: Cited Works Full text Published
  • Owner: Ferring B.v, Xanodyne Pharmaceuticals, Xanodyne Pharmaceuticals Inc, Mikart Inc
  • Applicant: Heasley Ralph A, Moore Keith A, Greiwe Jeffrey S, Facemire John W, Modest Jason D, Ferring Bv
Granted Patent
US 8968777 B2
166-717-099-712-372

Pharmaceutical Composition For Use In The Treatment Of A Neurodegenerative Disease

Granted Patent
US 9987332 B2
172-049-723-445-228

Tranexamic Acid Formulations

  • Published: May 24, 2011
  • Filed: Feb 26, 2010
  • Earliest Priority: Mar 04 2004
  • Family: 5
  • Cited Works: 102
  • Cited by: 10
  • Cites: 84
  • Additional Info: Cited Works Full text Published
  • Owner: Ferring B.v, Xanodyne Pharmaceuticals Inc, Mikart Inc
  • Applicant: Ferring Bv
Granted Patent
US 7947739 B2
150-166-107-506-634

Tranexamic Acid Formulations

  • Published: Sep 25, 2012
  • Filed: Aug 13, 2008
  • Earliest Priority: Mar 04 2004
  • Family: 10
  • Cited Works: 101
  • Cited by: 10
  • Cites: 86
  • Additional Info: Cited Works Full text Published
  • Owner: Ferring B.v, Xenodyne Pharmaceuticals, Xanodyne Pharmaceuticals Inc, Mikart Inc
  • Applicant: Moore Keith A, Heasley Ralph A, Greiwe Jeffrey S, Facemire John W, Modest Jason D, Ferring Bv
Granted Patent
US 8273795 B2
182-134-905-325-39X

Pharmaceutical Combination For Improving Glycemic Control As Add-on Therapy To Basal Insulin

  • Published: Nov 21, 2017
  • Filed: May 9, 2012
  • Earliest Priority: May 13 2011
  • Family: 29
  • Cited Works: 941
  • Cited by: 2
  • Cites: 510
  • Sequences: 2
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Sanofi-aventis Deutschland Gmbh
  • Applicant: Niemoeller Elisabeth, Silvestre Louise, Boka Gabor, Miossec Patrick, Sanofi Aventis Deutschland
Granted Patent
US 9821032 B2
138-229-978-160-983

Insulin Glargine/lixisenatide Fixed Ratio Formulation

  • Published: Apr 24, 2018
  • Filed: Dec 10, 2015
  • Earliest Priority: Dec 12 2014
  • Family: 23
  • Cited Works: 939
  • Cited by: 0
  • Cites: 514
  • Sequences: 2
  • Additional Info: Cited Works Full text Published Sequence
  • Owner: Sanofi-aventis Deutschland Gmbh, Saudi Arabian Oil Company
  • Applicant: Sanofi Aventis Deutschland
Granted Patent
US 9950039 B2
033-689-058-528-511
{{::'analysis.preview.CITED_WORKS_ANALYSIS.title' | message}} {{::'analysis.preview.view.full' | message}}

Add New Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save
Search ORCID

Sign in to the Lens

Forgot Password? Register New Account
Feedback